Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NorthStar Medical Radioisotopes, LLC
NorthStar Medical Radioisotopes and Convergent Therapeutics, Inc. Expand Strategic Collaboration Around CONV01-α
August 13, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Sponsors Study Entitled “Program to Find a Cure for ANCA-associated Vasculitis Through Research”
July 30, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production
July 22, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Marks Critical Milestone in Readiness for Clinical Batch Production
June 04, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes, LLC Enters Clinical Supply Agreement to Support Clarity Cu-67 SAR-bisPSMA Pivotal Trials
April 10, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2024 Jefferies Radiopharma Innovation Summit
April 04, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Long-term Agreement for Supply of Actinium-225 (Ac-225)
January 08, 2024
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Truist Securities Biopharma Symposium
November 06, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
August 29, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma
August 28, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)
July 18, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)
June 27, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Now Routinely Manufacturing High Activity Copper-67 on its Electron Accelerators for Clarity Pharmaceuticals' Therapy Clinical Programs
June 26, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Guggenheim Radiopharmaceuticals Day
May 09, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Expands Management Team with Appointment of Jean-Noel David, MBA, MS, as Vice President, Operations
April 18, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies
April 12, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones
April 03, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit
March 30, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)
March 01, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Sets New Industry Precedent in Advancing Non-uranium based Commercial Production of Molybdenum-99 (Mo-99)
January 11, 2023
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit
November 15, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
Radiopharm Theranostics Signs Agreement With NorthStar Medical Radioisotopes for the Supply of Non-Carrier Added (n.c.a.) Actinium-225
October 26, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
Tickers
ASX:RAD
Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
October 11, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes
September 20, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)
August 23, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Announces Supply Agreement with Clovis Oncology for Therapeutic Radioisotope Actinium-225 (Ac-225)
July 19, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and Curie Therapeutics Announce Priority Access Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
June 07, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Enhances Management Team with Appointment of Monica Andersen as Vice President, Human Resources
May 24, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones
March 29, 2022
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
NorthStar Medical Radioisotopes and IBA Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)
November 18, 2021
From
NorthStar Medical Radioisotopes, LLC
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.